<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04535180</url>
  </required_header>
  <id_info>
    <org_study_id>1-107-05-053</org_study_id>
    <nct_id>NCT04535180</nct_id>
  </id_info>
  <brief_title>Sarcopenia and Osteoporosis in the Patients With Hemophilia</brief_title>
  <official_title>Sarcopenia and Osteoporosis in the Patients With Hemophilia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tri-Service General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tri-Service General Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hemophilia is a bleeding disorder and repeated joint bleeding leads to hemophilic&#xD;
      arthropathy. Among patients with hemophilia, vitamin D deficiency and hemophilic arthropathy&#xD;
      have been associated with osteoporosis in several clinical studies.There is no data on the&#xD;
      prevalence of osteoporosis in hemophilia patients in Taiwan or Asia. To the best of our&#xD;
      knowledge, no previous studies have reported the prevalence of sarcopenia and correlation&#xD;
      with osteoporosis in hemophilia adult patients. This study will investigate the prevalence&#xD;
      and corelation of sarcopenia and low BMD in patients with hemophilia.&#xD;
&#xD;
      patients in Taiwan. The study will estimate the prevalence of sarcopenia and body composition&#xD;
      in the hemophilia population and compared baseline demographic and clinical characteristics&#xD;
      between the non-sarcopenia and sarcopenia individuals, with particular emphasis on the&#xD;
      overlap with osteoporosis and hemophilic arthropathy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Actual">December 31, 2019</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sacropenia</measure>
    <time_frame>up to 4 weeks</time_frame>
    <description>Extremity skeletal muscle mass will be calculated using the values measured via the DXA</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">45</enrollment>
  <condition>Sarcopenia</condition>
  <condition>Hemophilia</condition>
  <condition>Osteoporosis, Osteopenia</condition>
  <condition>Hemophilic Arthropathy</condition>
  <arm_group>
    <arm_group_label>Hemophilia</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Dual-energy X-ray absorptiometry (DXA)</intervention_name>
    <description>Body composition will be measured using whole-body DXA (GE Lunar iDXA, GE Healthcare Lunar, Madison, Wisconsin, U.S.A.). Extremity skeletal muscle mass will be calculated using the values measured via the DXA; ASM will be calculated as the sum of skeletal muscle mass in the arms and legs, assuming that the mass of lean soft tissue is a skeletal muscle. Appendicular skeletal mass index (ASM/Ht2 ) will be determined as the sum of the arm and leg lean mass (kg)/height2 (m2&#xD;
). BMD will be measured in lumbar spine and bilateral hip by the same DXA device (GE Lunar iDXA, GE Healthcare Lunar, Madison, Wisconsin, U.S.A.)</description>
    <arm_group_label>Hemophilia</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Hemophilia adult patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Hemophilia patients&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of total hip arthroplasty&#xD;
&#xD;
          -  History of instrumentation in lumbar spine&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Tri-Service General Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>114</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 12, 2020</study_first_submitted>
  <study_first_submitted_qc>August 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 1, 2020</study_first_posted>
  <last_update_submitted>August 29, 2020</last_update_submitted>
  <last_update_submitted_qc>August 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tri-Service General Hospital</investigator_affiliation>
    <investigator_full_name>Tsung-Ying Li</investigator_full_name>
    <investigator_title>Attending physician</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
    <mesh_term>Bone Diseases, Metabolic</mesh_term>
    <mesh_term>Joint Diseases</mesh_term>
    <mesh_term>Sarcopenia</mesh_term>
    <mesh_term>Hemophilia A</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

